Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Authors
Judith C. Kando (ORCID: https://orcid.org/0000-0002-6637-449X)
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Judith C. Kando, Leslie Citrome, Nichole M. Neugebauer, Alicia A Meli
Citations
5 citations
Journal
Neuropsychiatric Disease and Treatment
Topics
Psychotherapy Techniques and Applications
Field-Weighted Citation Impact (FWCI)
11.53
article
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Judith C. Kando, Leslie Citrome, Nichole M. Neugebauer, Alicia A Meli
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
Neuropsychiatric Disease and TreatmentVol. Volume 21
Institutions
New York Medical College (US), Bristol-Myers Squibb (United States) (US)